# Source:Dr. John Campbell, URL:https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg, language:en-UK

## UK surge continues
 - [https://www.youtube.com/watch?v=UFWICK4ePg0](https://www.youtube.com/watch?v=UFWICK4ePg0)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2022-03-29 00:00:00+00:00

Most common symptoms, Runny nose, 82% Fatigue, 70% Headache, 69%

Sore throat, 69%

Sneezing, 68%

Persistent cough, 53%

Hoarse, 46%

Chills or shivers, 36%

Joint pains, 33%

Fever, 32%

Dizzy, 30%

Brain fog, 27%

Sore eyes, 25%

Altered smell, 24%

Muscle pains, 23%

Lower back pain, 23%

Swollen glands, 21%

Skipped meals, 18%

Ear ringing, 17%

Covid more common than colds

Even if testing negative
UK

https://covid.joinzoe.com/data

ONS

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights


Percentage of the community population that had COVID-19 up to 19 March 2022

6.39% in England (1 in 16 people)

6.35% in Wales (1 in 16 people) 

5.92% in Northern Ireland 
(1 in 17 people) 

9.00% in Scotland (1 in 11 people)

Antibodies

99.0% in England

98.9% in Wales 

98.8% in Northern Ireland 

99.0% in Scotland

Unvaccinated pupils were more likely to become infected with COVID-19 in the Autumn 2021 term

Compared with unvaccinated pupils

Those aged 12 to 15 years,
who had received one vaccine dose more than 14 days ago: 

were 23% less likely to report a positive test

(second half of the Autumn 2021 term 4th  November to 17th  December 2021)

UK official data

https://coronavirus.data.gov.uk/

## US and China and BA 2
 - [https://www.youtube.com/watch?v=YoDvuu9oOzg](https://www.youtube.com/watch?v=YoDvuu9oOzg)
 - RSS feed: https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg
 - date published: 2022-03-28 00:00:00+00:00

The World Health Organization decides BA.2 is more transmissible than BA.1

https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---8-march-2022

https://www.nytimes.com/interactive/2022/03/28/opinion/coronavirus-mutation-future.html

Weekly epidemiological update on COVID-19

BA.2 is main global driver

Feb. 16th to March 17th 

BA.2 86% of global reports

BA.1 and BA.1.1, together 13%

BA.2 is more transmissible than BA.1

Not been shown to cause more severe illness

Dr. Maria Van Kerkhove

Our vaccines remain incredibly effective at preventing severe disease and death, including against both of the sublineages of BA.1 and BA.2

Deltacron

Shanghai

https://www.theguardian.com/world/2022/mar/28/shanghai-to-lock-down-millions-for-mass-testing-as-chinas-covid-cases-surge

Phased lockdown, 25 million people

Omicron wave 

Eastern side, under lockdown, Monday to Friday

Mass testing

Cases, 3,450 asymptomatic cases

(50 symptomatic cases)

Other citywide lockdowns

Vaccine effectiveness of two and three doses of BNT162b2 and CoronaVac against COVID-19 in Hong Kong

https://www.medrxiv.org/content/10.1101/2022.03.22.22272769v1

Three doses of either vaccine offered very high levels of protection against severe outcomes (VE: 98.1%)

Third doses of either BNT162b2 or CoronaVac provide substantial additional protection against severe COVID-19 and should be prioritized, 

particularly in older adults who received CoronaVac primary schedules.

US

Dr. Rochelle Walensky, BA.2, third of new cases

Paxlovid 

US, cases

https://covid.cdc.gov/covid-data-tracker/#datatracker-home
 

US deaths

 


US, hospital patients

 

 

https://covid19.healthdata.org/united-states-of-america?view=cumulative-deaths&tab=trend

A second booster for anyone 50 and older is expected soon (FDA, CDC)

Four months after thirds shot

